X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES WYETH LTD JUBILANT LIFE SCIENCES/
WYETH LTD
 
P/E (TTM) x 20.6 27.7 74.4% View Chart
P/BV x 4.4 5.3 82.0% View Chart
Dividend Yield % 0.4 1.3 32.6%  

Financials

 JUBILANT LIFE SCIENCES   WYETH LTD
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
WYETH LTD
Mar-13
JUBILANT LIFE SCIENCES/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1871,044 17.9%   
Low Rs65818 8.0%   
Sales per share (Unadj.) Rs364.3298.6 122.0%  
Earnings per share (Unadj.) Rs6.857.2 12.0%  
Cash flow per share (Unadj.) Rs24.558.4 41.9%  
Dividends per share (Unadj.) Rs3.0017.00 17.6%  
Dividend yield (eoy) %2.41.8 130.5%  
Book value per share (Unadj.) Rs164.9249.5 66.1%  
Shares outstanding (eoy) m159.2822.72 701.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.1 11.1%   
Avg P/E ratio x18.416.3 113.1%  
P/CF ratio (eoy) x5.115.9 32.2%  
Price / Book Value ratio x0.83.7 20.5%  
Dividend payout %43.829.7 147.6%   
Avg Mkt Cap Rs m20,06121,157 94.8%   
No. of employees `0006.20.5 1,257.1%   
Total wages/salary Rs m11,052400 2,762.9%   
Avg. sales/employee Rs Th9,383.013,787.4 68.1%   
Avg. wages/employee Rs Th1,786.9813.0 219.8%   
Avg. net profit/employee Rs Th176.32,643.3 6.7%   
INCOME DATA
Net Sales Rs m58,0346,783 855.5%  
Other income Rs m191353 54.1%   
Total revenues Rs m58,2247,136 815.9%   
Gross profit Rs m5,7861,617 357.8%  
Depreciation Rs m2,81227 10,570.3%   
Interest Rs m3,2376 58,858.2%   
Profit before tax Rs m-721,938 -3.7%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-5 -42,056.9%   
Tax Rs m696632 110.2%   
Profit after tax Rs m1,0901,301 83.8%  
Gross profit margin %10.023.8 41.8%  
Effective tax rate %-965.932.6 -2,960.6%   
Net profit margin %1.919.2 9.8%  
BALANCE SHEET DATA
Current assets Rs m29,2806,984 419.3%   
Current liabilities Rs m38,9122,056 1,892.7%   
Net working cap to sales %-16.672.6 -22.8%  
Current ratio x0.83.4 22.2%  
Inventory Days Days8499 85.0%  
Debtors Days Days5124 211.7%  
Net fixed assets Rs m55,712244 22,804.6%   
Share capital Rs m155227 68.0%   
"Free" reserves Rs m20,9685,441 385.4%   
Net worth Rs m26,2655,668 463.4%   
Long term debt Rs m17,16925 68,675.2%   
Total assets Rs m88,6067,901 1,121.4%  
Interest coverage x1.0353.3 0.3%   
Debt to equity ratio x0.70 14,820.1%  
Sales to assets ratio x0.70.9 76.3%   
Return on assets %4.916.5 29.5%  
Return on equity %4.222.9 18.1%  
Return on capital %11.634.0 34.0%  
Exports to sales %37.80.2 17,322.0%   
Imports to sales %16.536.3 45.4%   
Exports (fob) Rs m21,93315 148,193.9%   
Imports (cif) Rs m9,5672,465 388.1%   
Fx inflow Rs m22,00415 144,763.8%   
Fx outflow Rs m11,7492,677 438.9%   
Net fx Rs m10,255-2,662 -385.2%   
CASH FLOW
From Operations Rs m8,026923 869.4%  
From Investments Rs m-1,744317 -550.4%  
From Financial Activity Rs m-4,447-481 924.6%  
Net Cashflow Rs m1,834759 241.7%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 51.1 6.8%  
Indian inst/Mut Fund % 8.7 11.3 77.0%  
FIIs % 21.2 7.2 294.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 30.4 69.4%  
Shareholders   23,815 21,978 108.4%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 17, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS